The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
enGene Holdings Inc. Common Stock 29286M105   10,440,745 1,131,175 SH   SOLE   1,131,175 0 0
enGene Holdings Inc. Warrant 29286M113   403,815 475,077 SH   SOLE   475,077 0 0
Ikena Oncology Common Stock 45175G108   4,430,772 2,249,123 SH   SOLE   2,249,123 0 0
Immunic Inc Common Stock 4525EP101   2,682,240 1,788,160 SH   SOLE   1,788,160 0 0
Kronos Bio Common Stock 50107A104   4,772,854 3,818,283 SH   SOLE   3,818,283 0 0
Lexeo Therapeutics Common Stock 52886X107   28,955,301 2,157,623 SH   SOLE   2,157,623 0 0
Morphic Holding Common Stock 61775R105   8,948,352 309,846 SH   SOLE   309,846 0 0
Nuvation Bio Common Stock Class A 67080N101   22,759,233 15,072,340 SH   SOLE   15,072,340 0 0
Replimune Group Common Stock 76029N106   25,301,119 3,001,319 SH   SOLE   3,001,319 0 0
Sana Biotechnology, Inc. Common Stock 799566104   3,442,500 843,750 SH   SOLE   843,750 0 0
Senti Biosciences, Inc. Common Stock 81726A100   129,223 195,792 SH   SOLE   195,792 0 0
Spruce Biosciences Common Stock 85209E109   6,331,794 2,161,022 SH   SOLE   2,161,022 0 0
Syros Pharmaceuticals Common Stock 87184Q206   1,957,393 251,270 SH   SOLE   251,270 0 0
Theseus Pharmaceuticals Common Stock 88369M101   2,881,490 711,479 SH   SOLE   711,479 0 0